The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EORTC CLTF 2018 | ECP experience in Canada: prospects and challenges
Extracorporeal photopheresis (ECP) is known to be beneficial for the treatment of cutaneous T-cell lymphoma; however, there are challenges to it’s use, as discussed here by Robert Gniadecki, MD, PhD, of the University of Alberta, Edmonton, Canada, at the European Organisation for the Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force (CLTF) 2018 Congress, held in St. Gallen, Switzerland. Dr Gniadecki compares ECP to other current therapies and presents the issues of access to this therapy in Canada.
